High-flow nasal cannula versus noninvasive ventilation in patients with COVID-19: a systematic review and meta-analysis.

ABSTRACT:

Background

During the novel coronavirus disease 2019 (COVID-19) pandemic raging around the world, the effectiveness of respiratory support treatment has dominated people's field of vision. This study aimed to compare the effectiveness and value of high-flow nasal cannula (HFNC) with noninvasive ventilation (NIV) for COVID-19 patients.

Methods

A comprehensive systematic review via PubMed, Web of Science, Cochrane, Scopus, WHO database, China Biology Medicine Disc (SINOMED), and China National Knowledge Infrastructure (CNKI) databases was conducted, followed by meta-analysis. RevMan 5.4 was used to analyze the results and risk of bias. The primary outcome is the number of deaths at day 28. The secondary outcomes are the occurrence of invasive mechanical ventilation (IMV

SUBMITTER: He Y 

PROVIDER: S-EPMC8972939 | biostudies-literature | 2022 Jan-Dec

REPOSITORIES: biostudies-literature